Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Non-Current Liabilities: 2015-2023

Historic Other Non-Current Liabilities for Wave Life Sciences (WVE) over the last 6 years, with Jun 2023 value amounting to $190,000.

  • Wave Life Sciences' Other Non-Current Liabilities was N/A to $190,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $190,000, marking a year-over-year change of. This contributed to the annual value of $190,000 for FY2022, which is N/A change from last year.
  • As of Q2 2023, Wave Life Sciences' Other Non-Current Liabilities stood at $190,000, which was down 0.00% from $190,000 recorded in Q1 2023.
  • In the past 5 years, Wave Life Sciences' Other Non-Current Liabilities ranged from a high of $2.0 million in Q1 2019 and a low of $190,000 during Q4 2022.
  • For the 3-year period, Wave Life Sciences' Other Non-Current Liabilities averaged around $456,857, with its median value being $339,000 (2021).
  • In the last 5 years, Wave Life Sciences' Other Non-Current Liabilities soared by 113.27% in 2022 and then crashed by 78.11% in 2023.
  • Quarterly analysis of 5 years shows Wave Life Sciences' Other Non-Current Liabilities stood at $1.7 million in 2019, then tumbled by 72.46% to $474,000 in 2020, then dropped by 28.59% to $1.0 million in 2021, then surged by 113.27% to $190,000 in 2022, then crashed by 78.11% to $190,000 in 2023.
  • Its Other Non-Current Liabilities was $190,000 in Q2 2023, compared to $190,000 in Q1 2023 and $190,000 in Q4 2022.